NanoSpeed, incorporated in 2009, has developed proprietary diagnostic screening test kits platforms based on our Lateral Flow Immuno-Assay (LFIA). Our technological advancements provide our clients with cost-effective and reliable testing tools that address the increasing needs of the healthcare industry, regulatory agencies, and consumers. NanoSpeed Diagnostics Inc. is committed to delivering high-quality, accurate, and fast point-of-care testing for tomorrow’s health care reality.